August J. Troendle, 10% Owner, Director, President & CEO, on August 27, 2026, sold 650 shares in Medpace Holdings (MEDP) for $403,176. Following the Form 4 filing with the SEC, Troendle has control over a total of 5,272,913 common shares of the company, with 539,894 shares held directly and 4,733,019 controlled indirectly.
SEC Filing: